Biomarin Pharmaceutical (BMRN) Construction in Progress (2010 - 2013)

Biomarin Pharmaceutical has disclosed Construction in Progress across 4 years of filings, most recently posting $77.2 million for Q4 2013.

• Quarterly Construction in Progress rose 20.08% year-over-year to $77.2 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $77.2 million (up 20.08% YoY) and the FY2013 annual result came in at $77.2 million, up 20.08% from the prior year.
• Construction in Progress advanced to $77.2 million in Q4 2013, from $64.8 million in the prior quarter.
• Over five years, Construction in Progress peaked at $77.2 million in Q4 2013 and troughed at $14.7 million in Q4 2010.
• A 4-year average of $58.1 million and a median of $63.0 million in 2012 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2011 — Construction in Progress jumped 265.84% — and 2013, when it gained 10.66%.
• Tracing BMRN's Construction in Progress over 4 years: stood at $14.7 million in 2010, then soared by 265.84% to $53.9 million in 2011, then increased by 19.33% to $64.3 million in 2012, then advanced by 20.08% to $77.2 million in 2013.
• Business Quant data shows BMRN's Construction in Progress at $77.2 million in Q4 2013, $64.8 million in Q3 2013, and $68.2 million in Q2 2013.